EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC-ND 4.0

Radiotherapy combined with immunomodulator therapy for monomorphic epitheliotropic intestinal T‐cell lymphoma (MEITL) after surgery and chemotherapy: a case report

Liang Wei, Min Luo, Yongchang Wei

Precision Radiation Oncology · 18.11.2026

DOI: 10.1002/pro6.70091 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Precision Radiation Oncology, online erschienen am 18.11.2026. Verfasst von Liang Wei und 2 weiteren Autor:innen. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Monomorphic epitheliotropic intestinal T‐cell lymphoma (MEITL) is a mature T‐cell lymphoma that originates from intestinal intraepithelial T lymphocytes. It is a rare malignancy with a poor prognosis and a median overall survival of only 7 months. Currently, there is no standard treatment regimen for MEITL, and chemotherapy is the most commonly used approach. However, the application of radiotherapy and immunomodulators has rarely been reported. This report describes a case of MEITL in a middle‐aged male. The patient initially received CHOEP (cyclophosphamide, doxorubicin, vincristine, etoposide, and prednisone) chemotherapy but failed to complete the planned course owing to Grade IV leukopenia. Subsequently, the patient underwent whole abdominal radiotherapy (WART). After the completion of WART, the patient was continuously administered lenalidomide‐dexamethasone (LenDex). Excellent therapeutic efficacy was achieved, with no evidence of disease confirmed by regular post‐treatment follow‐up and disease‐free survival exceeding 24 months. The combination of WART and LenDex for MEITL has not been previously reported and its potential therapeutic value may provide valuable insights for clinical practice and future research.

Zitieren

APA

Wei, L., Luo, M., & Wei, Y. (2026). Radiotherapy combined with immunomodulator therapy for monomorphic epitheliotropic intestinal T‐cell lymphoma (MEITL) after surgery and chemotherapy: a case report. Precision Radiation Oncology. https://doi.org/10.1002/pro6.70091

Vancouver

Wei L, Luo M, Wei Y. Radiotherapy combined with immunomodulator therapy for monomorphic epitheliotropic intestinal T‐cell lymphoma (MEITL) after surgery and chemotherapy: a case report. Precision Radiation Oncology. 2026. doi:10.1002/pro6.70091

BibTeX
@article{Wei2026,
  author = {Wei, Liang and Luo, Min and Wei, Yongchang},
  title = {Radiotherapy combined with immunomodulator therapy for monomorphic epitheliotropic intestinal T‐cell lymphoma (MEITL) after surgery and chemotherapy: a case report},
  journal = {Precision Radiation Oncology},
  year = {2026},
  doi = {10.1002/pro6.70091}
}
Kostenlos starten →